Humira Pricing Takes Center Stage In Dutch Courts

AbbVie To Battle Human Rights Court Case

A public interest group has accused the pharma major of using excessive pricing to bolster sales of blockbuster Humira, consequently damaging the health of Dutch patients. 

Human rights
• Source: Shutterstock

More from Market Access

More from In Vivo